Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Circ J ; 75(11): 2635-41, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21828932

RESUMO

BACKGROUND: The influence of the number of diseased coronary arteries on the mobilization of CD133/45(+) bone marrow-derived circulating progenitor cells (BM-CPCs) in peripheral blood (PB) in patients with ischemic heart disease (IHD) was analyzed. METHODS AND RESULTS: Mobilization of CD133/45(+) BM-CPCs by flow cytometry was measured in 120 patients with coronary 1 vessel (IHD1, n=40), coronary 2 vessel (IHD2, n=40), and coronary 3 vessel disease (IHD3, n=40), and in a control group (n=40). The mobilization of CD133/45(+) BM-CPCs was significantly reduced in patients with IHD compared to the control group (P<0.001). The mobilization of CD133/45(+) BM-CPCs was impaired in patients with IHD3 compared to IHD1 (P<0.001) and to IHD2 (P<0.001). But there was no significant difference in mobilization of CD133/45(+) BM-CPCs between the patients with IHD2 and IHD1 (P=0.35). Moreover, we found significantly reduced CD133/45(+) cell mobilization in patients with a high SYNTAX-Score (SS) compared to a low SS (P<0.001) and an intermediate SS (P<0.001). In subgroup analyzes, we observed a significantly negative correlation between levels of hemoglobin A(1c) and the mobilization of CD133/45(+) BM-CPCs (P=0.001, r=-0.6). CONCLUSIONS: The mobilization of CD133/45(+) BM-CPCs in PB is impaired in patients with IHD. This impairment might augment with increased number of diseased coronary arteries. Moreover, mobilization of CD133/45(+) BM-CPCs in ischemic tissue is further impaired by diabetes in patients with IHD.


Assuntos
Antígenos CD , Células da Medula Óssea , Complicações do Diabetes/sangue , Glicoproteínas , Mobilização de Células-Tronco Hematopoéticas , Isquemia Miocárdica/sangue , Peptídeos , Células-Tronco , Antígeno AC133 , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Complicações do Diabetes/patologia , Feminino , Citometria de Fluxo/métodos , Humanos , Antígenos Comuns de Leucócito , Masculino , Pessoa de Meia-Idade , Isquemia Miocárdica/patologia
2.
Med Klin (Munich) ; 104(11): 878-81, 2009 Nov 15.
Artigo em Alemão | MEDLINE | ID: mdl-19916078

RESUMO

BACKGROUND: Both, acute and chronic aortic insufficiency, can be caused by various conditions. While the acute form is often associated with an endocarditis, type A aortic dissection and trauma, one possible cause of chronic aortic insufficiency is a congenital malformation of the aortic valve. Among these malformations, the quadricuspid aortic valve is the most rare form. The diagnosis is often made by Doppler echocardiography, during cardiac surgery, or postmortem. CASE REPORT: A 44-year-old female patient presented with a 2-year history of increasing dyspnea on exertion. The physical examination revealed a diastolic heart murmur in the second right intercostal space and a blood pressure of 170/60 mmHg. Transthoracic and transesophageal Doppler echocardiography disclosed a quadricuspid aortic valve with severe aortic insufficiency. After implantation of a mechanical aortic valve, the patient was clinically well. CONCLUSION: Quadricuspid aortic valve, often associated with aortic insufficiency, is a rare condition. The diagnosis can be made by Doppler echocardiography. The special treatment should be based on objective and subjective findings. In the absence of severe aortic regurgitation or clinical signs, a medical treatment with close follow-up is justified. In case of severe aortic regurgitation or clinical signs of cardiac decompensation, surgical treatment is recommended.


Assuntos
Insuficiência da Valva Aórtica/congênito , Valva Aórtica/anormalidades , Adulto , Anticoagulantes/administração & dosagem , Insuficiência da Valva Aórtica/diagnóstico , Insuficiência da Valva Aórtica/cirurgia , Aortografia , Quimioterapia Combinada , Dispneia/etiologia , Ecocardiografia Transesofagiana , Feminino , Humanos , Cuidados Pós-Operatórios , Desenho de Prótese
3.
Coron Artery Dis ; 19(6): 413-9, 2008 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-18955835

RESUMO

INTRODUCTION: For the prevention of contrast-induced nephropathy (CIN) after coronary angiography, hydration by 0.9% sodium chloride solution and N-acetylcysteine is currently recommended. However, it is unclear whether volume supplementation with sodium bicarbonate is better than with sodium chloride when used in conjunction with nonionic, low-osmolar iopamidol. The aim of this study was to analyze and compare the effects of sodium bicarbonate and sodium chloride on renal function in 145 patients exposed to nonionic iso-osmolar contrast medium iodixanol in a randomized study. PATIENTS AND METHODS: Renal Insufficiency Following Radiocontrast Exposure is a prospective, randomized, single-center, double-blinded trial of 145 patients (age 72.6+/-6.7 years) with elevated baseline serum creatinine levels (mean 132.6+/-29.3 micromol/l). Eligible patients were randomized to either a 154 mEq/l infusion of sodium bicarbonate (n=71, group I) or sodium chloride 0.9% solution (n=74, group II). The primary endpoint was serum creatinine elevation beyond 25% or 44 micromol/l on the first or second day following exposure to the contrast medium. Serum creatinine, serum cystatin C, plasma viscosity, urinary enzymes alanine aminopeptidase and N-acetyl-beta-D-glucosaminidase, and alpha1-microglobulin were measured at baseline and on days 1 and 2 after contrast medium administration. RESULTS: An overall proportion of five CIN (3.4%) was observed with equal distribution among the groups (4.2% in sodium bicarbonate group vs. 2.7% in sodium chloride group; P=0.614). Parameters of renal function demonstrated no differences between the two hydration regimens on day 1 after angiography; even on day 2 most parameters were similar in groups I and II. CONCLUSION: Renal Insufficiency Following Radiocontrast Exposure demonstrates a homogeneously low rate of CIN after exposure to nonionic, iso-osmolar iodixanol regardless of the use of either bicarbonate sodium or sodium chloride solution for volume supplementation. Low-toxicity contrast media and any hydration may offset potential antioxidant effects of sodium bicarbonate.


Assuntos
Meios de Contraste/efeitos adversos , Hidratação/métodos , Insuficiência Renal/prevenção & controle , Bicarbonato de Sódio/administração & dosagem , Cloreto de Sódio/administração & dosagem , Ácidos Tri-Iodobenzoicos/efeitos adversos , Adulto , Idoso , Idoso de 80 Anos ou mais , Meios de Contraste/administração & dosagem , Angiografia Coronária/efeitos adversos , Angiografia Coronária/métodos , Doença das Coronárias/diagnóstico por imagem , Método Duplo-Cego , Feminino , Seguimentos , Humanos , Injeções Intravenosas , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Insuficiência Renal/induzido quimicamente , Resultado do Tratamento , Ácidos Tri-Iodobenzoicos/administração & dosagem
4.
Wien Klin Wochenschr ; 120(1-2): 46-9, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18239991

RESUMO

Kytoccoccus schroeteri is an emerging pathogen found mainly in association with prosthetic valve endocarditis. A striking aspect of this species is its resistance to penicillins, including isoxazolylpenicillins, making glycopeptide administration and valve replacement the treatment of choice. We present the case of a 38-year-old female diabetic patient with fever up to 39.1 degrees C for two months. Infection of her prosthetic aortic valve was suspected clinically. Repeated blood cultures revealed growth of K. schroeteri. Transesophageal echocardiography demonstrated a vegetation on the prosthetic aortic valve. Antibiotic treatment with vancomycin, rifampin and gentamicin was started and this regimen led to complete resolution of symptoms and disappearance of the vegetation. It is of particular interest that the patient recovered without further surgical procedures. Since the first description of K. schroeteri in 2002, four cases of endocarditis have been published, suggesting antecedent and continuing underdiagnosis.


Assuntos
Infecções por Actinomycetales/microbiologia , Actinomycetales/patogenicidade , Insuficiência da Valva Aórtica/cirurgia , Endocardite Bacteriana/microbiologia , Próteses Valvulares Cardíacas/microbiologia , Infecções por Actinomycetales/diagnóstico , Adulto , DNA Bacteriano/genética , Esquema de Medicação , Farmacorresistência Bacteriana Múltipla , Quimioterapia Combinada , Ecocardiografia Transesofagiana , Endocardite Bacteriana/diagnóstico , Feminino , Gentamicinas/administração & dosagem , Humanos , Testes de Sensibilidade Microbiana , Ofloxacino/administração & dosagem , Reação em Cadeia da Polimerase , Rifampina/administração & dosagem , Vancomicina/administração & dosagem
5.
Basic Clin Pharmacol Toxicol ; 96(6): 445-52, 2005 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15910408

RESUMO

This study was designed to compare the effects of purified antibodies against the beta(1)-adrenoceptor autoantibodies and total immunoglobulin G obtained during immunoadsorption on L-type Ca(2+) currents, action potentials and cell shortening, in rat ventricular myocytes. Patients with dilated cardiomyopathy frequently develop autoantibodies against beta(1)-adrenoceptors, which can be removed by immunoadsorption. There is some controversy, however, whether the beneficial effects of this therapeutic option are due to the removal of cardiostimulatory or cardiodepressive antibodies. Therefore we studied the effects of immunoglobulin G on two of the regulators of excitation-contraction coupling and on cell shortening. Immunoglobulin G was obtained during immunoadsorption therapy. Dissociated myocytes from rat hearts were electrically stimulated and cell shortening was measured by cell edge detection. Single electrode patch clamp technique in current or voltage clamp mode was used to measure L-type Ca(2+) currents or action potentials, respectively. (-)-Isoprenaline was used for comparative purposes. In comparison to (-)-isoprenaline, immunoglobulin G increased Ca(2+) current to a similar extent, but prolonged the plateau duration of action potentials to a lesser extent. Immunoglobulin G and beta(1)-adrenoceptor enhanced cell shortening to a similar degree, however, the effects were smaller than with (-)-isoprenaline. The increase in contraction amplitude was prevented by (-)-bisoprolol. We conclude that both beta(1)-adrenoceptors and immunoglobulin G derived from patients positive for beta(1)-adrenoceptor autoantibodies mediate the cardiostimulatory effects via beta(1)-adrenoceptors.


Assuntos
Autoanticorpos/farmacologia , Cardiomiopatia Dilatada/imunologia , Imunoglobulina G/farmacologia , Miócitos Cardíacos/efeitos dos fármacos , Potenciais de Ação/efeitos dos fármacos , Agonistas Adrenérgicos beta/farmacologia , Animais , Cálcio/metabolismo , Canais de Cálcio Tipo L/metabolismo , Tamanho Celular/efeitos dos fármacos , Ventrículos do Coração/citologia , Ventrículos do Coração/efeitos dos fármacos , Humanos , Imunoterapia/métodos , Isoproterenol/farmacologia , Miócitos Cardíacos/citologia , Técnicas de Patch-Clamp , Ratos , Ratos Wistar , Receptores Adrenérgicos beta 1/imunologia
6.
Herz ; 29(6): 582-8, 2004 Sep.
Artigo em Alemão | MEDLINE | ID: mdl-15912432

RESUMO

In patients with an acute chest pain syndrome the primary requirement is to diagnose or exclude acute myocardial ischemia or myocardial infarction. However, only 30% of patients admitted and evaluated for chest pain ultimately reveal the diagnosis of acute coronary syndrome.Traditionally, the initial evaluation of patients presenting with chest discomfort or pain to an emergency department or any general practice involves the triad of history, physical examination, and ECG and chest film evaluation. With the diagnostic routine of bedside enzymatic tests for cardiac biomarkers, it has become easier to identify acute coronary syndromes, but at the same time more compelling to pinpoint other differential diagnoses, once coronary syndromes are excluded. When a cardiac origin of any non-suggestive chest pain syndrome has been excluded, a broad spectrum of other causes for noncardiac chest pain needs to be evaluated. Potential underlying disorders are listed in this overview and grouped according to pathoanatomic origin into aortic, respiratory, and gastroesophageal disorders, musculoskeletal pathology, and somatization disorders. This article reviews both symptoms and diagnostic pathways in patients with noncardiac chest pain, and eventually offers a rational strategy for an efficacious workup of a wide spectrum of important differential diagnoses.


Assuntos
Doenças da Aorta/diagnóstico , Dor no Peito/diagnóstico , Gastroenteropatias/diagnóstico , Doenças Musculoesqueléticas/diagnóstico , Pericardite/diagnóstico , Medição de Risco/métodos , Traumatismos Torácicos/diagnóstico , Doenças da Aorta/complicações , Dor no Peito/etiologia , Doença da Artéria Coronariana/complicações , Doença da Artéria Coronariana/diagnóstico , Diagnóstico Diferencial , Gastroenteropatias/complicações , Humanos , Doenças Musculoesqueléticas/complicações , Isquemia Miocárdica/complicações , Isquemia Miocárdica/diagnóstico , Pericardite/complicações , Guias de Prática Clínica como Assunto , Padrões de Prática Médica , Prognóstico , Fatores de Risco , Traumatismos Torácicos/complicações
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...